Dr. Dambinova has 42 years of experience in Molecular Neurobiology, Neurochemistry and Laboratory Medicine. During the last two decades, Dr. Dambinova spent her academic career at Emory University, Kennesaw State University, Emory Healthcare (Atlanta, USA), and I.M. Sechenov First Moscow State Medical University (Moscow, Russia). Her long-term professional collaboration with clinicians and educators worldwide guided her research to biomarkers utilities for acute brain injuries including stroke and TBI. Dr. Dambinova was Principal Investigator in 10 Federal, Industrial, and Innovative Grants and guided a number of International clinical studies. Her research accomplishments were awarded by the American Association for Clinical Chemistry in 2003-2004, by 4th International Conference “Biochemical Markers for Brain Damage” in 2005, by National Academy of Clinical Biochemistry award at AACC 2009-2010 meetings, and by International Stroke Conference in 2013 for outstanding research in the field of Brain Biomarkers in Laboratory Medicine.

She has published more than 350 scientific papers, 30 book chapters, 42 global patents, and 8 books including her latest books, “Biomarkers for TBI” (RSC Publishing House, London, UK, 2012), “Biomarkers for Cerebral Ischemia”, (Kosta Publishing, St. Petersburg, Russia 2013), “Acute Brain Impairment: Scientific Discoveries and Translational Research” (RSC Publishing House, London, UK, 2018), and “Stroke Biomarkers”, Neuromethods series (Humana Press, New York, 2020).

Svetlana Dambinova, PhD Distinguished Professor, Brain Biomarkers Research Lab, Emory Decatur Hospital, Emory Healthcare, Decatur, GA, USA

Dr. Dambinova has 42 years of experience in Molecular Neurobiology, Neurochemistry and Laboratory Medicine. During the last two decades, Dr. Dambinova spent her academic career at Emory University, Kennesaw State University, Emory Healthcare (Atlanta, USA), and I.M. Sechenov First Moscow State Medical University (Moscow, Russia). Her long-term professional collaboration with clinicians and educators worldwide guided her research to biomarkers utilities for acute brain injuries including stroke and TBI. Dr. Dambinova was Principal Investigator in 10 Federal, Industrial, and Innovative Grants and guided a number of International clinical studies. Her research accomplishments were awarded by the American Association for Clinical Chemistry in 2003-2004, by 4th International Conference “Biochemical Markers for Brain Damage” in 2005, by National Academy of Clinical Biochemistry award at AACC 2009-2010 meetings, and by International Stroke Conference in 2013 for outstanding research in the field of Brain Biomarkers in Laboratory Medicine.

She has published more than 350 scientific papers, 30 book chapters, 42 global patents, and 8 books including her latest books, “Biomarkers for TBI” (RSC Publishing House, London, UK, 2012), “Biomarkers for Cerebral Ischemia”, (Kosta Publishing, St. Petersburg, Russia 2013), “Acute Brain Impairment: Scientific Discoveries and Translational Research” (RSC Publishing House, London, UK, 2018), and “Stroke Biomarkers”, Neuromethods series (Humana Press, New York, 2020).

No products were found matching your selection.